
|Videos|May 2, 2022
A discourse in clinical study timelines and the need for acceleration in retina research
Author(s)David Hutton, Emily Kaiser Maharjan
Dr. David Bingaman of Ora Clinical discusses today’s need to accelerate clinical studies and increase investments in retina and challenging disease states.
Advertisement
David Hutton, executive editor of Ophthalmology Times®, sits down with David Bingaman, DVM, PhD, Chief Development Officer of Ora Clinical to discuss the need to accelerate clinical trials and increase investments in retina research. Dr. Bingaman also discusses Ora Clinical’s presence at ARVO 2022.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Ophthalmic care uncommon after tamoxifen initiation
2
Training refractive surgeons and expanding access to eye surgery
3
Empire Forum 2026: Ambati on K8 phase 2 results in geographic atrophy
4
Looking beyond visual acuity in macular telangiectasia
5















